daltex 50 mg/1000 mg filmom obalené tablety
medochemie ltd., cyprus - metformín a vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
daltex 50 mg/850 mg filmom obalené tablety
medochemie ltd., cyprus - metformín a vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
vildagliptin/metformin sandoz 50 mg/1000 mg
sandoz pharmaceuticals d.d., slovinsko - metformín a vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
vildagliptin/metformin sandoz 50 mg/850 mg
sandoz pharmaceuticals d.d., slovinsko - metformín a vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
vildagliptin/metformin stada 50 mg/1000 mg filmom obalené tablety
stada arzneimittel ag, nemecko - metformín a vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
vildagliptin/metformin stada 50 mg/850 mg filmom obalené tablety
stada arzneimittel ag, nemecko - metformín a vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
vimetso 50 mg/1000 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - metformín a vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
vimetso 50 mg/850 mg filmom obalené tablety
krka, d.d., novo mesto, slovinsko - metformín a vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
eucreas
novartis europharm limited - vildagliptin, hydrochlorid metformín - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, hydrochlorid metformín - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pre dostupné údaje o rôznych kombináciách).